Pneumonia due to infection with P. aeruginosa occur as three distinct syndromes:

1. Community-acquired pneumonia (CAP), usually affects persons with chronic lung disease.
2. Hospital-acquired pneumonia (HAP), commonly occurs in ICU patients.
3. Bacteremic P. aeruginosa, mostly in neutropenic hosts [1].

P. aeruginosa colonization can occur in airways damaged due to mechanical ventilation or a preceding viral infection, or trauma and is usually followed by acute pneumonia, sepsis, and death. As an etiology of ventilator-associated pneumonia, P. aeruginosa has a high mortality rate compared to other organisms [2]. The incidence of P. aeruginosa pneumonia is increased in patients with chronic obstructive pulmonary disease (COPD), nursing home residents, and patients recently discharged from a hospital [3].

Patients aged over 65 are at an increased risk for mortality from the bacteremic pneumococcal disease. In elderly persons, the expression of common signs and symptoms of pneumonia are usually obscured, atypical, or even absent [4] [5] [6].

Symptoms of pneumonia include a productive cough, severe dyspnea, fever, chills, cyanosis, confusion, and signs of systemic inflammatory response. On physical examination, fever, cyanosis, rales, rhonchi, retractions, and hypoxia may be detected. In patients with cystic fibrosis, clubbing, malnutrition, and an increased anteroposterior (AP) chest diameter can develop.

If pneumonia is suspected, blood gas analysis to assess the presence of hypoxia or hypercarbia should be performed and sputum and respiratory secretions have to be cultured. However, isolating Pseudomonas from tracheal secretions and sputum may reveal airway colonization. Sputum has a poor sensitivity and specificity for identifying the bacterial etiology of pneumonia, therefore in patients who are on mechanical ventilation quantitative cultures are obtained through bronchoalveolar lavage and specimen brushings.

Community-acquired pneumonia is diagnosed by clinical presentation (e.g. fever, cough, pleuritic chest pain) and by observing infiltrates on chest radiography. Sputum and blood cultures are rarely useful for outpatients and usually ordered for severely ill inpatients [7].

A chest radiography with lateral and posteroanterior views [8] may show focal or diffuse opacities but in immunosuppressed patients, especially those suffering from diabetes, uremia, neutropenia or alcoholism, the appearance of the infiltrates can be delayed. Other findings on the radiograph suggestive of pneumonia include parapneumonic effusions, air bronchograms, and the silhouette signs. P. aeruginosa has a predilection for lower lobes of the lungs. The involvement may be bilateral and extensive, or unilateral. Massive consolidation can occur but has a poor prognosis. Patchy bronchopneumonia, necrosis, abscess formation, and nodular infarcts are other possible findings. Complications of pneumonia such as atelectasis or lung abscesses may also be detected. In patients with existing structural lung diseases, the appearance of the signs of pneumonia on radiography will not be straightforward.

The use of computed tomography (CT) scan has increased in clinical practice, but its usefulness in assessing pneumonia has been questioned with various reports suggesting that CT scan should be limited to the following settings:

• Examination of patients with neutropenia and fever of unknown origin (ultra-thin section CT scan).
• To confirm the presence of pleural effusion.
• Evaluating an abnormal, indistinct opacity detected on chest radiography.
• Assessment of opacities on chest radiographs that appear patchy, linear/reticular, or have a ground-glass appearance.

Treatment of Pseudomonas pneumonia typically involves antibiotics. However, due to the bacterium's resistance to many drugs, selecting the right antibiotic is crucial. Commonly used antibiotics include piperacillin-tazobactam, ceftazidime, or ciprofloxacin. In some cases, a combination of antibiotics may be necessary. Treatment duration can vary, but it often requires a longer course than other bacterial pneumonias.

The prognosis for Pseudomonas pneumonia depends on several factors, including the patient's overall health, the severity of the infection, and how quickly treatment is started. Patients with weakened immune systems or underlying health conditions may have a more challenging recovery. Early diagnosis and appropriate treatment are key to improving outcomes.

Pseudomonas pneumonia is caused by the bacterium Pseudomonas aeruginosa. This organism is commonly found in the environment, including soil, water, and hospital settings. It can cause infections when it enters the body, particularly in individuals with compromised immune systems or those with chronic lung conditions.

Pseudomonas pneumonia is more prevalent in hospital settings, particularly among patients in intensive care units or those with mechanical ventilation. It is less common in the general population. The bacterium is known for its ability to survive in moist environments, making it a frequent cause of hospital-acquired infections.

Pseudomonas aeruginosa can invade the lungs and cause inflammation and damage to lung tissue. The bacterium produces toxins that can destroy cells and disrupt normal lung function. Its ability to form biofilms, which are protective layers that shield it from antibiotics, contributes to its resistance and persistence in the body.

Preventing Pseudomonas pneumonia involves measures to reduce exposure to the bacterium, especially in hospital settings. This includes strict hand hygiene, proper sterilization of medical equipment, and isolation of infected patients. For individuals with chronic lung conditions, maintaining good respiratory health and avoiding known risk factors can help reduce the risk of infection.

Pseudomonas pneumonia is a serious lung infection caused by the bacterium Pseudomonas aeruginosa. It primarily affects individuals with weakened immune systems or those in hospital settings. Diagnosis involves clinical evaluation and laboratory tests, while treatment requires specific antibiotics due to the bacterium's resistance. Early intervention is crucial for a better prognosis.

If you or a loved one is diagnosed with Pseudomonas pneumonia, it's important to follow the treatment plan prescribed by your healthcare provider. This may include taking antibiotics as directed and attending follow-up appointments. Maintaining good hygiene and being aware of infection control practices can help prevent the spread of the bacterium.

1. Fujitani S, Sun HY, Yu VL, Weingarten JA. Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest. 2011;139(4):909-19.
2. Chastre J, Fragon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867–903.
3. Ruiz M, Ewig S, Torres A, et al. Severe community-acquired pneumonia: risk factors and follow up epidemiology. Am J Respir Crit Care Med 1999;160:923–939.
4. Metaly JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med. 1997;157(13):1453-9.
5. Venkatesan P, Gladman J, Macfarlane JT, et al. A hospital study of community acquired pneumonia in the elderly. Thorax. 1990;45(4):254-8.
6. Marrie TJ, Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc. 1997;45(1):50-5.
7. Watkins RR, Lemonovich TL. Diagnosis and management of community-acquired pneumonia in adults. Am Fam Physician. 2011;83(11):1299-306.
8. Franquet T. Imaging of pneumonia: trends and algorithms. Eur Respir J. 2001;18(1):196-208.